Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2022

May 25, 2022

30150_dirs_2022-05-25_8d121741-affc-4fb7-9bae-ba02a5f6b147.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-05-23

Reporting Person: Wise John Drayton (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 51901 Direct